Volume | 980,090 |
|
|||||
News | - | ||||||
Day High | 5.00 | Low High |
|||||
Day Low | 4.562 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Savara Inc | SVRA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.91 | 4.562 | 5.00 | 4.655 | 5.07 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
8,553 | 980,090 | $ 4.76 | $ 4,660,638 | - | 1.86 - 5.70 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:54:45 | 1 | $ 4.51 | USD |
Savara Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
642.39M | 138.15M | - | 0 | -54.7M | -0.40 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Savara News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SVRA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.78 | 5.31 | 4.562 | 5.02 | 936,453 | -0.125 | -2.62% |
1 Month | 5.31 | 5.33 | 4.06 | 4.87 | 1,149,908 | -0.655 | -12.34% |
3 Months | 5.00 | 5.70 | 4.06 | 4.96 | 871,573 | -0.345 | -6.90% |
6 Months | 3.58 | 5.70 | 3.115 | 4.67 | 900,104 | 1.08 | 30.03% |
1 Year | 1.86 | 5.70 | 1.86 | 4.14 | 721,840 | 2.80 | 150.27% |
3 Years | 1.63 | 5.70 | 1.02 | 2.96 | 444,715 | 3.03 | 185.58% |
5 Years | 10.86 | 11.96 | 0.69 | 2.69 | 695,534 | -6.21 | -57.14% |
Savara Description
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). |